Related Experiment Video
Updated: Apr 12, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Justin D Dang1, Lindsay E Davis
1Justin D. Dang is a staff pharmacist at Banner Estrella Medical Center in Phoenix, Ariz. Lindsay E. Davis is an assistant professor at Midwestern University's College of Pharmacy in Glendale, Ariz. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Chronic liver disease has long been considered the prime example of acquired bleeding disorders due to its associated coagulopathies, namely elevated international normalized ratio (INR) and thrombocytopenia. Recent evidence has shown that patients with chronic liver disease also are at risk for hospital-acquired venous thromboembolism (VTE). The safety and efficacy of low-dose anticoagulants for VTE prophylaxis have not been firmly established in this patient population. However, recent studies also indicate pharmacologic VTE prophylaxis can be used with caution in hospitalized patients with chronic liver disease.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pulmonary Embolism III: Nursing Management

